Literature DB >> 20980285

Improvement of HbA1c during treatment with humanised anti-interleukin 6 receptor antibody, tocilizumab.

Atsushi Ogata, Atsuyoshi Morishima, Toru Hirano, Yoshihiro Hishitani, Keisuke Hagihara, Yoshihito Shima, Masashi Narazaki, Toshio Tanaka.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20980285     DOI： 10.1136/ard.2010.132845

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  30 in total

Review 1.  Adipocytokines in obesity and metabolic disease.

Authors:  Haiming Cao
Journal:  J Endocrinol       Date:  2014-01-08       Impact factor: 4.286

Review 2.  The role of interleukin-6 in glucose homeostasis and lipid metabolism.

Authors:  Louise Lang Lehrskov; Regitse Højgaard Christensen
Journal:  Semin Immunopathol       Date:  2019-05-17       Impact factor: 9.623

3.  NCOA5 haploinsufficiency results in glucose intolerance and subsequent hepatocellular carcinoma.

Authors:  Shenglan Gao; Aimin Li; Feiye Liu; Fengsheng Chen; Mark Williams; Chengliang Zhang; Zakiya Kelley; Chin-Lee Wu; Rongcheng Luo; Hua Xiao
Journal:  Cancer Cell       Date:  2013-12-09       Impact factor: 31.743

4.  Obesity and metabolic inflammation.

Authors:  Haiyan Xu
Journal:  Drug Discov Today Dis Mech       Date:  2013-06-01

Review 5.  IL-6 signalling pathways and the development of type 2 diabetes.

Authors:  Mohamad Akbari; Vahideh Hassan-Zadeh
Journal:  Inflammopharmacology       Date:  2018-03-05       Impact factor: 4.473

Review 6.  Cardiovascular safety of biologic therapies for the treatment of RA.

Authors:  Jeffrey D Greenberg; Victoria Furer; Michael E Farkouh
Journal:  Nat Rev Rheumatol       Date:  2011-11-15       Impact factor: 20.543

Review 7.  Interleukin-6 blockade in ocular inflammatory diseases.

Authors:  M Mesquida; A Leszczynska; V Llorenç; A Adán
Journal:  Clin Exp Immunol       Date:  2014-06       Impact factor: 4.330

Review 8.  Adipose tissue inflammation in glucose metabolism.

Authors:  H L Kammoun; M J Kraakman; M A Febbraio
Journal:  Rev Endocr Metab Disord       Date:  2014-03       Impact factor: 6.514

Review 9.  Immune-Modulating Therapy for Rheumatologic Disease: Implications for Patients with Diabetes.

Authors:  Scott J Pilla; Amy Q Quan; Emily L Germain-Lee; David B Hellmann; Nestoras N Mathioudakis
Journal:  Curr Diab Rep       Date:  2016-10       Impact factor: 4.810

10.  Interleukin-6 amplifies glucagon secretion: coordinated control via the brain and pancreas.

Authors:  Tammy M Barnes; Yolanda F Otero; Amicia D Elliott; Alicia D Locke; Carlo M Malabanan; Anastasia G Coldren; Marcela Brissova; David W Piston; Owen P McGuinness
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-09-09       Impact factor: 4.310
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.